OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
05/03/2026
Voltar para busca
Dado oficial do USPTO
POOLBEG PHARMA
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
28
Atualização mais recente
03/04/2026
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
5, 35, 42
Data de depósito
30/11/2023
Data de registro
15/07/2025
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
15/07/2025
Última transação
03/04/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
3
Tipo de titular
99
Localização do titular
GB
Examinador
FARRAG, SHERIF G
Unidade examinadora
M70
Localização atual
FILE REPOSITORY (FRANCONIA)
Descrição da marca
The mark consists of the stylized dark blue wording "POOLBEG" above the stylized navy blue wording "PHARMA" with the wordings adjacent to two red and grey smokestacks, all above a horizontal navy blue line.
Titulares e representantes
Titulares
POOLBEG PHARMA (UK) LIMITED
Representantes
Usha Menon D'Ambrosio & Menon, PLLC
Classificação técnica
Classes Nice
Classe 5Classe 35Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Pharmaceuticalspsychotropicsantihelminticslipid lowering agentspharmaceuticals for the treatment of skin disordersdermatological conditionsrespiratory diseases and asthmacancerbaldnessheart diseasecardiovascular disordersallergiesmuscle injuries and disorderserectile dysfunctionviral diseaseshormonal disordersinfectious diseasesbone diseasesstretch markseyes diseases and eye conditionsgastro-intestinal diseasespsychiatric diseases and disordersimmune system related diseases and disordersinsomnianeuropathic painsinus congestionblood disorderspaininflammationobesity and cognitive disordersocular diseases or disordersbacteria-based diseases or disordersautoimmune diseases or disorderskidney diseases or disordersdiabetes; vaccinesreagents for medical use; medical and veterinary preparations for the diagnosis and treatment of infectious diseases; sanitary preparations for medical purposes; dietetic foods and beverages adapted for medical or veterinary usefood for babies; dietary supplements for human beings and animals; medical and surgical plastersmaterials for dressings being gauze for medical and surgical dressings and wadding for medical and surgical dressings; material for stopping teethdental wax; disinfectants; preparations for destroying vermin; fungicidesherbicides
Classe 35
Advertising services for pharmaceuticalsreagents for medical usemedical drugs and vaccines; advertising services relating to pharmaceuticals; business management in the field of pharmaceuticalsreagents for medical usemedical drugs and vaccines; business advisory services in the field of pharmaceuticalsreagents for medical usemedical drugs and vaccines; business administration in the field of pharmaceuticalsreagents for medical usemedical drugs and vaccines; commercial consultancy in the field of pharmaceuticalsreagents for medical usemedical drugs and vaccines; commercial intermediation servicesnamely business intermediary services relating to the matching of buyers and sellers of medical products in the field of pharmaceuticalsreagents for medical usemedical drugs and vaccines; negotiating and concluding commercial transactions for others in the field of pharmaceuticalsreagents for medical usemedical drugs and vaccines; providing business assistance in the field of pharmaceuticalsreagents for medical usemedical drugs and vaccine product commercialization; commercial lobbying services in the field of pharmaceuticalsreagents for medical usemedical drugs and vaccines; commercial information in the field of pharmaceuticalsreagents for medical usemedical drugs and vaccines; commercial management assistance in the field of pharmaceuticalsreagents for medical usemedical drugs and vaccines; preparation of commercial business reports in the field of pharmaceuticalsreagents for medical usemedical drugs and vaccines; collection of commercial information being market research information relating to the field of pharmaceuticalsreagents for medical usemedical drugs and vaccines; provision of information concerning commercial sales relating to the field of pharmaceuticalsreagents for medical usemedical drugs and vaccines; compilation of business statistics and commercial information relating to the field of pharmaceuticalsmedical drugs and vaccines; business management consultancy and advisory services relating to the field of pharmaceuticalsmedical drugs and vaccines; computerised business management for others relating to the field of pharmaceuticalsmedical drugs and vaccines; provision of commercial information from online databases relating to the field of pharmaceuticalsreagents for medical usemedical drugs and vaccines; business management of reimbursement programmes for others relating to the field of pharmaceuticalsreagents for medical usemedical drugs and vaccines; business administration of medication reimbursement programs and services; provision of an online marketplace for buyers and sellers of pharmaceuticalsreagents for medical usemedical drugs and vaccines; sales promotion for others of pharmaceuticalsreagents for medical usemedical drugs and vaccines; business opportunity promotion in the field of pharmaceuticalsreagents for medical usemedical drugs and vaccines; promotion servicesadvertising services for the promotion of goods and services of others; promotional and advertising services; promoting the sale of goods and services of others through promotional events in the field of pharmaceuticalsreagents for medical usemedical drugs and vaccines; database management relating to pharmaceuticalsreagents for medical usemedical drugsvaccines and medical trials; database marketingadvertisingpromotion relating to pharmaceuticalsreagents for medical usemedical drugsvaccines and medical trialsfor others; compiling of information into computer databases relating to pharmaceuticalsreagents for medical usemedical drugsvaccines and medical trials; compilation of information into computer databases relating to pharmaceuticalsreagents for medical usemedical drugsvaccines and medical trials; retail and online retail store services or wholesale store services for pharmaceuticalveterinary and sanitary preparations and medical supplies; retail and online retail store services or wholesale store services relating to medical instruments and devicespharmaceuticalsreagents for medical usedrugs and vaccines
Classe 42
Scientific and technological services being the scientific research relating to pharmaceuticalsreagents for medical usemedical drugsvaccines and medical clinical trialsdesign relating thereto; industrial research services in the field of pharmaceuticalsreagents for medical usemedical drugsvaccines and medical clinical trials and industrial analysis thereof; design and development of computer hardware and software; software as a service (SAAS) services featuring software for use in the communication and dissemination of medical and pharmaceutical information and for providing clinical trial information and results; providing onlinenon-downloadable software for the communication and dissemination of medical and pharmaceutical information and for providing clinical trial information and results; hosting online web facilities for others for conducting interactive discussions; hosting of digital content online being the electronic storage of electronic data; online data storage being cloud storage services for electronic data; platform as a service (PAAS) featuring computer software platforms for use in the communication and dissemination of medical and pharmaceutical information and for providing clinical trial information and results; hosting software platforms for collaboration on medical and pharmaceutical products on the Internet for others; hosting of communication platforms being software for others on the internet; hosting of e-commerce platforms being software for others on the Internet; scientific research services and the preparation of technical reports relating to pharmaceuticalsreagents for medical usedrugs and vaccines thereto; technical research relating to pharmaceuticalsreagents for medical usemedical drugs and vaccines; providing scientific information in the field of medical disorders and their treatment; database design and development; design and development of pharmaceuticalmedical drugvaccine and medical trial databases; maintaining online databases for scientific research purposes of pharmaceuticalsmedical drugsvaccines and medical trials for others; medical and pharmacological research services; medical research relating to pharmaceuticalsreagents for medical usemedical drugs and vaccines; scientific research for medical purposes; provision of information and data relating to medical and veterinary research and development; research and development in the field of biotechnology; biotechnology testing being scientific research in the field of biotechnology; testing of pharmaceuticals for quality control purposes for others; technical testing services relating to pharmaceuticalsreagents for medical usemedical drugs and vaccines being quality control services for others; testingauthentication and evaluation being quality control of pharmaceuticalsreagents for medical usemedical drugs and vaccines; scientific and technological consultancy relating to biotechnology; electronic storage of medical records; medical research laboratory services; design and development of medical technology; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; scientific research in the nature of conducting clinical trials for others; research and development of vaccines and medicines; drug discovery services; pharmaceutical drug development services; pharmaceutical research services; pharmaceutical product evaluation; pharmaceutical research and development services
Publicações
Histórico de despachos e eventos da marca no USPTO.
28 publicações encontradas
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
26/02/2026
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
18/02/2026
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
18/02/2026
FICS
FINAL DISPOSITION NOTICE SENT TO IB
11/02/2026
FIMP
FINAL DISPOSITION PROCESSED
11/02/2026
LIMN
LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
29/10/2025
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
15/10/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
15/07/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
15/07/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
27/05/2025
PUBO
PUBLISHED FOR OPPOSITION
27/05/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
21/05/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
29/04/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
13/04/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
13/04/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
13/04/2025
LIMG
LIMITATION OF GOODS RECEIVED FROM IB
20/12/2024
RFNT
REFUSAL PROCESSED BY IB
09/11/2024
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
24/10/2024
RFRR
REFUSAL PROCESSED BY MPU
24/10/2024
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
19/10/2024
CNRT
NON-FINAL ACTION WRITTEN
18/10/2024
DOCK
ASSIGNED TO EXAMINER
25/09/2024
MAFR
APPLICATION FILING RECEIPT MAILED
24/09/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
24/09/2024
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
24/09/2024
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
19/09/2024
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace POOLBEG PHARMA ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.